Current Report Filing (8-k)
April 29 2016 - 2:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 27, 2016
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
MICHIGAN
|
|
0-17988
|
|
38-2367843
|
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
|
620 Lesher Place Lansing, Michigan
|
|
48912
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code 517-372-9200
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.01 Completion of Acquisition of Disposition of Assets
On April 27, 2016, Neogen Corporation (“Company”) issued a press release announcing that, effective that same date, it had
acquired Brazil-based Deoxi Biotecnologia Ltda (Deoxi) — a leading animal genomics laboratory in the country with the most cattle in the world.
The
acquisition of Deoxi is intended to help accelerate the growth of Neogen’s GeneSeek animal genomics in Brazil, which is home to more than 200 million cattle (as a comparison, the United States is home to approximately 90 million
cattle). Deoxi was founded in 2008, and was a competitor of Neogen’s in the livestock genomics market. The Deoxi laboratory will remain in Araçatuba, in Sao Paulo state, and offers the Company’s customers the benefits of dealing
directly with a Brazilian location.
A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report,
regardless of any general incorporation language in the filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
|
|
|
|
|
|
|
99.1
|
|
Press Release dated April 27, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NEOGEN CORPORATION
|
|
|
|
|
|
|
|
(Registrant)
|
|
Date: April 29, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Steven J. Quinlan
|
|
|
|
|
|
|
|
Steven J. Quinlan
|
|
|
|
|
|
|
|
Vice President & CFO
|
Neogen (NASDAQ:NEOG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neogen (NASDAQ:NEOG)
Historical Stock Chart
From Apr 2023 to Apr 2024
